Tinabinol

Tinabinol
INN: SP-119
Clinical data
Drug classCannabinoid
ATC code
  • None
Identifiers
  • 5,5-dimethyl-8-(3-methyl-2-octanyl)-1,2,3,5-tetrahydrothiopyrano[2,3-c]chromen-10-ol
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC23H34O2S
Molar mass374.58 g·mol−1
3D model (JSmol)
  • O3c1cc(cc(O)c1\C2=C(\SCCC2)C3(C)C)C(C)C(C)CCCCC
  • InChI=1S/C23H34O2S/c1-6-7-8-10-15(2)16(3)17-13-19(24)21-18-11-9-12-26-22(18)23(4,5)25-20(21)14-17/h13-16,24H,6-12H2,1-5H3
  • Key:YCNTYPIGYVTFBO-UHFFFAOYSA-N

Tinabinol (INN: SP-119) is a synthetic cannabinoid drug and analogue of dronabinol (Δ9-tetrahydrocannabinol) and dimethylheptylpyran which was patented as an antihypertensive but was never marketed.[1][2]

See also

References

  1. ^ Brown DT (19 November 1998). Cannabis: The Genus Cannabis. CRC Press. p. 80. ISBN 978-90-5702-291-3. Retrieved 27 April 2012.
  2. ^ Negwer M (1994). Organic-chemical drugs and their synonyms: an international survey. Indices. Akad.-Verl. p. 2242. ISBN 978-3-05-501629-5. Retrieved 27 April 2012.


Stub icon

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.